Per ulteriori informazioni selezionare i riferimenti di interesse.
Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment
EXPERT OPINION ON BIOLOGICAL THERAPY
Melanoma of the head and neck: Current concepts in diagnosis and management
Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV
Vascular involvement in the prognosis of primary cutaneous melanoma
ARCHIVES OF DERMATOLOGY
Treatment of maxillary sinus carcinoma - A comparison of the 1997 and 1977American Joint Committee on Cancer staging systems